Retatrutide × NextGen Peptides - Lab Test, January 2026
Test results
About this test
Retatrutide 30mg from NextGen Peptides achieves 99.806% purity according to this independent HPLC analysis conducted by Janoshik Labs on January 22, 2026. The tested quantity was 34.32mg, exceeding the stated label amount of 30mg.
Retatrutide is a triple GIP/GLP-1/glucagon receptor agonist researched for metabolic regulation, weight management, and glycemic control. A purity level of 99.806% demonstrates pharmaceutical-grade synthesis with minimal contamination and high product consistency.
The certificate of analysis (Task #101808) is available for verification at www.janoshik.com/verify/ with the unique key JN6L7AM64INX. The test includes assessment of the peptide vial or vials.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.